(Q33407127)
Statements
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034 (English)
Martin J B Taphoorn
Denis Lacombe
Thierry Gorlia
Marc Frenay
Roy Rampling
Antoine F Carpentier
Paul M Clement
Mario Campone
Jean-Francois Baurain
Jean-Paul Armand
Alicia Tosoni
Heidemarie Kletzl
Barbara Klughammer
9 February 2009